AI heart screening for cardiomyopathy using CT scans
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This trial uses an artificial intelligence system to analyze coronary CT scans (CCTA) to help detect various types of heart muscle diseases called cardiomyopathies. The goal is to see if the AI can catch signs of these conditions earlier, possibly leading to quicker diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a cardiomyopathy, such as hypertrophic cardiomyopathy, dilated cardiomyopathy, or others like cardiac amyloidosis or myocarditis.
- You have had at least one coronary CT scan (CCTA) before any heart surgery or before getting a device like a pacemaker or defibrillator implanted.
- You do not have a heart condition caused by another disease, such as from a systemic illness.
- If you are in the control group, you have had a CCTA scan without any known heart disease.
- You can provide medical records confirming your diagnosis and CT scan history.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to help diagnose and predict outcomes for people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes thickened. It may help doctors better understand your condition and plan your care.
This study uses artificial intelligence to analyze ECGs and echoes from people with hypertrophic cardiomyopathy (HCM) to improve how the disease is detected and managed. If you have HCM with a thickened heart wall and available heart tests, you may help train the AI.
This study uses artificial intelligence to look for signs of heart artery disease on a CT scan that doesn't require dye. It's for people with stable chest pain who have already had a specific type of CT scan.
This study uses artificial intelligence (AI) to look at your heart tests (ECG and echo) and find people who might have a specific heart muscle disease called ATTR-CM. The goal is to catch it earlier so treatment can start sooner.
This study uses artificial intelligence to analyze your heart CT scan and better predict your risk of coronary artery disease (narrowing of the arteries that supply your heart). The goal is to help doctors identify who might need earlier treatment or more careful monitoring.
This study at Mayo Clinic is testing an artificial intelligence (AI) tool that analyzes echocardiograms (ultrasound of the heart) to find early signs of four types of heart muscle disease. If the AI flags a high-risk pattern, doctors can learn whether acting on that alert helps catch the condition sooner.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.